PT UBC Medical Indonesia Tbk (IDX:LABS)
Indonesia flag Indonesia · Delayed Price · Currency is IDR
150.00
+1.00 (0.67%)
Apr 29, 2026, 9:25 AM WIB

IDX:LABS Ratios and Metrics

Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
588,550541,150529,300---
Market Cap Growth
30.70%2.24%----
Enterprise Value
574,888543,513545,030---
Last Close Price
149.00137.00134.00---
PE Ratio
43.5740.07179.29---
PS Ratio
2.952.723.59---
PB Ratio
3.863.553.82---
P/TBV Ratio
3.983.663.97---
P/FCF Ratio
67.7962.33----
P/OCF Ratio
25.7123.64----
EV/Sales Ratio
2.882.733.69---
EV/EBITDA Ratio
17.2916.4725.81---
EV/EBIT Ratio
28.2326.6960.88---
EV/FCF Ratio
66.2262.61----
Debt / Equity Ratio
0.180.180.260.840.412.82
Debt / EBITDA Ratio
0.830.831.682.631.542.31
Debt / FCF Ratio
3.173.17----
Net Debt / Equity Ratio
-0.09-0.09-0.050.770.391.57
Net Debt / EBITDA Ratio
-0.41-0.41-0.312.451.541.32
Net Debt / FCF Ratio
-1.57-1.570.32-1.10-1.02-0.45
Asset Turnover
0.920.920.811.020.92-
Inventory Turnover
1.581.581.381.771.70-
Quick Ratio
1.021.021.180.410.300.23
Current Ratio
2.532.533.021.230.990.70
Return on Equity (ROE)
9.28%9.28%3.14%4.52%10.00%-
Return on Assets (ROA)
5.90%5.90%3.08%2.71%2.08%-
Return on Invested Capital (ROIC)
10.76%11.59%4.56%2.68%4.73%1.55%
Return on Capital Employed (ROCE)
13.10%13.10%5.90%8.30%7.00%28.60%
Earnings Yield
2.29%2.50%0.56%---
FCF Yield
1.48%1.60%-3.87%---
Buyback Yield / Dilution
---67.78%---
Source: S&P Global Market Intelligence. Standard template. Financial Sources.